NASDAQ:IRTC

Irhythm Technologies Stock News

Healthcare > Medical - Devices

Buy IRTC

*Your capital is at risk

$117.17

-1.91 (-1.60%)

At Close: Jul 31, 2026

Ethic Inc. Buys New Shares in iRhythm Technologies $IRTC

03:26am, Friday, 31'st Oct 2025

Ethic Inc. bought a new stake in iRhythm Technologies (NASDAQ: IRTC) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

09:06pm, Thursday, 30'th Oct 2025

iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & D

iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates

06:45pm, Thursday, 30'th Oct 2025

iRhythm Technologies (IRTC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $1.26 per share a year ago.

iRhythm Technologies Announces Third Quarter 2025 Financial Results

04:05pm, Thursday, 30'th Oct 2025

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven

State of New Jersey Common Pension Fund D Trims Stock Holdings in iRhythm Technologies $IRTC

04:35am, Thursday, 30'th Oct 2025

State of New Jersey Common Pension Fund D trimmed its holdings in iRhythm Technologies (NASDAQ: IRTC) by 18.7% during the undefined quarter, according to the company in its most recent Form 13F filing

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

05:00pm, Thursday, 23'rd Oct 2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

04:30pm, Thursday, 16'th Oct 2025

SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

01:30pm, Thursday, 18'th Sep 2025

NEW YORK and NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announce

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

05:01pm, Tuesday, 09'th Sep 2025

iRhythm Technologies, Inc. (NASDAQ:IRTC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT Company Participants Quentin Blackford - President, CEO & Director Confe

IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection

02:35pm, Tuesday, 02'nd Sep 2025

iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

07:00am, Friday, 29'th Aug 2025

SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led A ctive M onitoring for A tria L FI brillation (AMALFI) rando

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by